Liquidia Corp (LQDA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
14.23 +0.11 (+0.78%) 04/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 14.23 unch (unch) 16:24 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LQDA | ADPT | PCRX | ||
| Company | Liquidia Corp | Adaptive Biotechnologies Corp | Pacira Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 14.11 | 7.92 | 25.85 | ||
| High | 14.39 | 8.05 | 27.18 | ||
| Low | 14.02 | 7.71 | 25.44 | ||
| Last | 14.23 | 7.77 | 27.14 | ||
| Change | +0.11 | -0.13 | +1.42 | ||
| % Change | +0.78% | -1.65% | +5.52% | ||
| Volume | 595,900 | 1,138,400 | 1,447,900 | ||
| 20-Day Average Volume | 1,133,210 | 2,258,220 | 993,625 | ||
| Previous Close | 14.12 | 7.90 | 25.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.57 | 7.62 | 24.94 | ||
| 20-Day Raw Stochastic | 77.55% | 56.59% | 91.45% | ||
| 20-Day Relative Strength | 51.57% | 51.05% | 59.51% | ||
| Weighted Alpha | +30.78 | +124.97 | +76.01 | ||
| Today's Opinion | 40% Buy | 56% Buy | 100% Buy | ||
| Previous Opinion | 40% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 88% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.07% since 04/21/25 | +13.76% since 04/21/25 | +4.79% since 04/21/25 | ||
| Low | 13.13 on 04/22/25 | 6.90 on 04/22/25 | 25.08 on 04/23/25 | ||
| High | 14.39 on 04/28/25 | 8.05 on 04/28/25 | 27.18 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -5.70% since 03/28/25 | +1.30% since 03/28/25 | +8.95% since 03/28/25 | ||
| Low | 11.26 on 04/09/25 | 6.68 on 04/04/25 | 21.79 on 04/07/25 | ||
| High | 15.09 on 04/01/25 | 8.61 on 04/09/25 | 27.64 on 04/08/25 | ||
| 3-Month | |||||
| %Chg | +0.21% since 01/28/25 | -1.02% since 01/28/25 | +5.40% since 01/28/25 | ||
| Low | 11.26 on 04/09/25 | 6.26 on 03/11/25 | 21.79 on 04/07/25 | ||
| High | 16.81 on 02/20/25 | 9.01 on 03/24/25 | 27.64 on 04/08/25 | ||
| 6-Month | |||||
| %Chg | +29.01% since 10/28/24 | +66.38% since 10/28/24 | +58.44% since 10/28/24 | ||
| Low | 9.71 on 11/19/24 | 4.27 on 11/21/24 | 16.00 on 11/18/24 | ||
| High | 16.81 on 02/20/25 | 9.01 on 03/24/25 | 27.64 on 04/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,100,357 | 1,109,908 | 1,068,976 | ||
| Shares Outstanding, K | 85,299 | 148,582 | 46,276 | ||
| Annual Sales | 14,000,000 | 178,960,000 | 700,970,000 | ||
| Annual Net Income | -130,390,000 | -159,490,000 | -99,560,000 | ||
| Last Quarter Sales | 2,920,000 | 47,460,000 | 187,250,000 | ||
| Last Quarter Net Income | -38,370,000 | -33,690,000 | 16,040,000 | ||
| 60-Month Beta | 0.23 | 1.73 | 0.71 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 03/19/25 | -0.23 on 02/11/25 | 0.91 on 02/27/25 | ||
| Latest Earnings Date | 05/12/25 | 05/01/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.18 | ||